世界の胃抗分泌薬市場2020年:製造業者別、地域別、種類・用途別

【英語タイトル】Global Gastric Antisecretory Drug Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP11444)・商品コード:GIR20SP11444
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月25日(※2024年版があります。お問い合わせください)
・ページ数:108
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、胃抗分泌薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。胃抗分泌薬の種類別市場規模(H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他)、用途別市場規模(消化不良、消化性潰瘍、胃食道逆流、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Bayer、Takeda、Jiangsu Aosaikang、Cadila Pharmaceuticals、Altana Pharma、AstraZeneca、Luoxin、Pfizer、Eisai、NCPC
・地域別グローバル市場分析 2015年-2020年
・胃抗分泌薬の北米市場(アメリカ、カナダ、メキシコ)
・胃抗分泌薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・胃抗分泌薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・胃抗分泌薬の南米市場(ブラジル、アルゼンチン)
・胃抗分泌薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:H2受容体拮抗薬、胃プロトンポンプ阻害薬、その他
・用途別分析:消化不良、消化性潰瘍、胃食道逆流、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The Gastric Antisecretory Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Gastric Antisecretory Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Gastric Antisecretory Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Gastric Antisecretory Drug market has been segmented into
H2-receptor Antagonists
Gastric Proton Pump Inhibitors
Others

By Application, Gastric Antisecretory Drug has been segmented into:
Dyspepsia
Peptic Ulcer
Gastroesophageal Reflux
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastric Antisecretory Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastric Antisecretory Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastric Antisecretory Drug market.

The report offers in-depth assessment of the growth and other aspects of the Gastric Antisecretory Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Gastric Antisecretory Drug Market Share Analysis
Gastric Antisecretory Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastric Antisecretory Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastric Antisecretory Drug sales, revenue and market share for each player covered in this report.

The major players covered in Gastric Antisecretory Drug are:
Bayer
Takeda
Jiangsu Aosaikang
Cadila Pharmaceuticals
Altana Pharma
AstraZeneca
Luoxin
Pfizer
Eisai
NCPC

Among other players domestic and global, Gastric Antisecretory Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastric Antisecretory Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastric Antisecretory Drug, with price, sales, revenue and global market share of Gastric Antisecretory Drug in 2018 and 2019.
Chapter 3, the Gastric Antisecretory Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastric Antisecretory Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastric Antisecretory Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastric Antisecretory Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Gastric Antisecretory Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastric Antisecretory Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 H2-receptor Antagonists
1.2.3 Gastric Proton Pump Inhibitors
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastric Antisecretory Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dyspepsia
1.3.3 Peptic Ulcer
1.3.4 Gastroesophageal Reflux
1.3.5 Others
1.4 Overview of Global Gastric Antisecretory Drug Market
1.4.1 Global Gastric Antisecretory Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda SWOT Analysis
2.2.4 Takeda Product and Services
2.2.5 Takeda Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Jiangsu Aosaikang
2.3.1 Jiangsu Aosaikang Details
2.3.2 Jiangsu Aosaikang Major Business
2.3.3 Jiangsu Aosaikang SWOT Analysis
2.3.4 Jiangsu Aosaikang Product and Services
2.3.5 Jiangsu Aosaikang Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cadila Pharmaceuticals
2.4.1 Cadila Pharmaceuticals Details
2.4.2 Cadila Pharmaceuticals Major Business
2.4.3 Cadila Pharmaceuticals SWOT Analysis
2.4.4 Cadila Pharmaceuticals Product and Services
2.4.5 Cadila Pharmaceuticals Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Altana Pharma
2.5.1 Altana Pharma Details
2.5.2 Altana Pharma Major Business
2.5.3 Altana Pharma SWOT Analysis
2.5.4 Altana Pharma Product and Services
2.5.5 Altana Pharma Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Product and Services
2.6.4 AstraZeneca Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Luoxin
2.7.1 Luoxin Details
2.7.2 Luoxin Major Business
2.7.3 Luoxin Product and Services
2.7.4 Luoxin Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Product and Services
2.8.4 Pfizer Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business
2.9.3 Eisai Product and Services
2.9.4 Eisai Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 NCPC
2.10.1 NCPC Details
2.10.2 NCPC Major Business
2.10.3 NCPC Product and Services
2.10.4 NCPC Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastric Antisecretory Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastric Antisecretory Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastric Antisecretory Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Gastric Antisecretory Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastric Antisecretory Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Gastric Antisecretory Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastric Antisecretory Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
4.3 Europe Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
4.5 South America Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastric Antisecretory Drug Sales, Revenue and Market Share by Country
5.1.1 North America Gastric Antisecretory Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastric Antisecretory Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
5.3 Canada Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastric Antisecretory Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Gastric Antisecretory Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastric Antisecretory Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6.3 UK Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6.4 France Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6.5 Russia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
6.6 Italy Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastric Antisecretory Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastric Antisecretory Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastric Antisecretory Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.3 Japan Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.4 Korea Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.5 India Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
7.7 Australia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastric Antisecretory Drug Sales, Revenue and Market Share by Country
8.1.1 South America Gastric Antisecretory Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastric Antisecretory Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastric Antisecretory Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastric Antisecretory Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastric Antisecretory Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastric Antisecretory Drug Sales and Market Share by Type (2015-2020)
10.2 Global Gastric Antisecretory Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Gastric Antisecretory Drug Price by Type (2015-2020)
11 Global Gastric Antisecretory Drug Market Segment by Application
11.1 Global Gastric Antisecretory Drug Sales Market Share by Application (2015-2020)
11.2 Global Gastric Antisecretory Drug Revenue Market Share by Application (2015-2020)
11.3 Global Gastric Antisecretory Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastric Antisecretory Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastric Antisecretory Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Gastric Antisecretory Drug Market Forecast (2021-2025)
12.2.2 Europe Gastric Antisecretory Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastric Antisecretory Drug Market Forecast (2021-2025)
12.2.4 South America Gastric Antisecretory Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastric Antisecretory Drug Market Forecast (2021-2025)
12.3 Gastric Antisecretory Drug Market Forecast by Type (2021-2025)
12.3.1 Global Gastric Antisecretory Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Gastric Antisecretory Drug Market Share Forecast by Type (2021-2025)
12.4 Gastric Antisecretory Drug Market Forecast by Application (2021-2025)
12.4.1 Global Gastric Antisecretory Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Gastric Antisecretory Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Gastric Antisecretory Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastric Antisecretory Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastric Antisecretory Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Gastric Antisecretory Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Bayer Basic Information, Manufacturing Base and Competitors
Table 9. Bayer Gastric Antisecretory Drug Major Business
Table 10. Bayer Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 11. Bayer SWOT Analysis
Table 12. Bayer Gastric Antisecretory Drug Product and Services
Table 13. Bayer Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Takeda Basic Information, Manufacturing Base and Competitors
Table 15. Takeda Gastric Antisecretory Drug Major Business
Table 16. Takeda Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 17. Takeda SWOT Analysis
Table 18. Takeda Gastric Antisecretory Drug Product and Services
Table 19. Takeda Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Jiangsu Aosaikang Basic Information, Manufacturing Base and Competitors
Table 21. Jiangsu Aosaikang Gastric Antisecretory Drug Major Business
Table 22. Jiangsu Aosaikang Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 23. Jiangsu Aosaikang SWOT Analysis
Table 24. Jiangsu Aosaikang Gastric Antisecretory Drug Product and Services
Table 25. Jiangsu Aosaikang Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 27. Cadila Pharmaceuticals Gastric Antisecretory Drug Major Business
Table 28. Cadila Pharmaceuticals Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 29. Cadila Pharmaceuticals SWOT Analysis
Table 30. Cadila Pharmaceuticals Gastric Antisecretory Drug Product and Services
Table 31. Cadila Pharmaceuticals Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Altana Pharma Basic Information, Manufacturing Base and Competitors
Table 33. Altana Pharma Gastric Antisecretory Drug Major Business
Table 34. Altana Pharma Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 35. Altana Pharma SWOT Analysis
Table 36. Altana Pharma Gastric Antisecretory Drug Product and Services
Table 37. Altana Pharma Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Gastric Antisecretory Drug Major Business
Table 40. AstraZeneca Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 41. AstraZeneca SWOT Analysis
Table 42. AstraZeneca Gastric Antisecretory Drug Product and Services
Table 43. AstraZeneca Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Luoxin Basic Information, Manufacturing Base and Competitors
Table 45. Luoxin Gastric Antisecretory Drug Major Business
Table 46. Luoxin Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 47. Luoxin SWOT Analysis
Table 48. Luoxin Gastric Antisecretory Drug Product and Services
Table 49. Luoxin Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Pfizer Basic Information, Manufacturing Base and Competitors
Table 51. Pfizer Gastric Antisecretory Drug Major Business
Table 52. Pfizer Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 53. Pfizer SWOT Analysis
Table 54. Pfizer Gastric Antisecretory Drug Product and Services
Table 55. Pfizer Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Eisai Basic Information, Manufacturing Base and Competitors
Table 57. Eisai Gastric Antisecretory Drug Major Business
Table 58. Eisai Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 59. Eisai SWOT Analysis
Table 60. Eisai Gastric Antisecretory Drug Product and Services
Table 61. Eisai Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. NCPC Basic Information, Manufacturing Base and Competitors
Table 63. NCPC Gastric Antisecretory Drug Major Business
Table 64. NCPC Gastric Antisecretory Drug Total Revenue (USD Million) (2018-2019)
Table 65. NCPC SWOT Analysis
Table 66. NCPC Gastric Antisecretory Drug Product and Services
Table 67. NCPC Gastric Antisecretory Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Global Gastric Antisecretory Drug Sales by Manufacturer (2018-2019) (K Units)
Table 69. Global Gastric Antisecretory Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 70. Global Gastric Antisecretory Drug Sales by Regions (2015-2020) (K Units)
Table 71. Global Gastric Antisecretory Drug Sales Market Share by Regions (2015-2020)
Table 72. Global Gastric Antisecretory Drug Revenue by Regions (2015-2020) (USD Million)
Table 73. North America Gastric Antisecretory Drug Sales by Countries (2015-2020) (K Units)
Table 74. North America Gastric Antisecretory Drug Sales Market Share by Countries (2015-2020)
Table 75. North America Gastric Antisecretory Drug Revenue by Countries (2015-2020) (USD Million)
Table 76. North America Gastric Antisecretory Drug Revenue Market Share by Countries (2015-2020)
Table 77. Europe Gastric Antisecretory Drug Sales by Countries (2015-2020) (K Units)
Table 78. Europe Gastric Antisecretory Drug Sales Market Share by Countries (2015-2020)
Table 79. Europe Gastric Antisecretory Drug Revenue by Countries (2015-2020) (USD Million)
Table 80. Asia-Pacific Gastric Antisecretory Drug Sales by Regions (2015-2020) (K Units)
Table 81. Asia-Pacific Gastric Antisecretory Drug Sales Market Share by Regions (2015-2020)
Table 82. Asia-Pacific Gastric Antisecretory Drug Revenue by Regions (2015-2020) (USD Million)
Table 83. South America Gastric Antisecretory Drug Sales by Countries (2015-2020) (K Units)
Table 84. South America Gastric Antisecretory Drug Sales Market Share by Countries (2015-2020)
Table 85. South America Gastric Antisecretory Drug Revenue by Countries (2015-2020) (USD Million)
Table 86. South America Gastric Antisecretory Drug Revenue Market Share by Countries (2015-2020)
Table 87. Middle East & Africa Gastric Antisecretory Drug Sales by Countries (2015-2020) (K Units)
Table 88. Middle East & Africa Gastric Antisecretory Drug Sales Market Share by Countries (2015-2020)
Table 89. Middle East & Africa Gastric Antisecretory Drug Revenue by Countries (2015-2020) (USD Million)
Table 90. Middle East & Africa Gastric Antisecretory Drug Revenue Market Share by Countries (2015-2020)
Table 91. Global Gastric Antisecretory Drug Sales by Type (2015-2020) (K Units)
Table 92. Global Gastric Antisecretory Drug Sales Share by Type (2015-2020)
Table 93. Global Gastric Antisecretory Drug Revenue by Type (2015-2020) (USD Million)
Table 94. Global Gastric Antisecretory Drug Revenue Share by Type (2015-2020)
Table 95. Global Gastric Antisecretory Drug Sales by Application (2015-2020) (K Units)
Table 96. Global Gastric Antisecretory Drug Sales Share by Application (2015-2020)
Table 97. Global Gastric Antisecretory Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 98. Global Gastric Antisecretory Drug Market Share Forecast by Regions (2021-2025)
Table 99. Global Gastric Antisecretory Drug Sales Forecast by Type (2021-2025) (K Units)
Table 100. Global Gastric Antisecretory Drug Market Share Forecast by Type (2021-2025)
Table 101. Global Gastric Antisecretory Drug Sales Forecast by Application (2021-2025)
Table 102. Global Gastric Antisecretory Drug Market Share Forecast by Application (2021-2025)
Table 103. Direct Channel Pros & Cons
Table 104. Indirect Channel Pros & Cons
Table 105. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gastric Antisecretory Drug Picture
Figure 2. Global Sales Market Share of Gastric Antisecretory Drug by Type in 2019
Figure 3. H2-receptor Antagonists Picture
Figure 4. Gastric Proton Pump Inhibitors Picture
Figure 5. Others Picture
Figure 6. Gastric Antisecretory Drug Sales Market Share by Application in 2019
Figure 7. Dyspepsia Picture
Figure 8. Peptic Ulcer Picture
Figure 9. Gastroesophageal Reflux Picture
Figure 10. Others Picture
Figure 11. Global Gastric Antisecretory Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Gastric Antisecretory Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Gastric Antisecretory Drug Sales Market Share by Manufacturer in 2019
Figure 32. Global Gastric Antisecretory Drug Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Gastric Antisecretory Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Gastric Antisecretory Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Gastric Antisecretory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Gastric Antisecretory Drug Revenue Market Share by Regions (2015-2020)
Figure 39. Global Gastric Antisecretory Drug Revenue Market Share by Regions in 2018
Figure 40. North America Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
Figure 41. Europe Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
Figure 43. South America Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Gastric Antisecretory Drug Sales and Growth Rate (2015-2020)
Figure 45. North America Gastric Antisecretory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Gastric Antisecretory Drug Sales Market Share by Countries (2015-2020)
Figure 47. North America Gastric Antisecretory Drug Sales Market Share by Countries in 2018
Figure 48. North America Gastric Antisecretory Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Gastric Antisecretory Drug Revenue Market Share by Countries in 2018
Figure 50. United States Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Gastric Antisecretory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Gastric Antisecretory Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Gastric Antisecretory Drug Revenue Market Share by Countries in 2019
Figure 56. Germany Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Gastric Antisecretory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Gastric Antisecretory Drug Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Gastric Antisecretory Drug Revenue Market Share by Regions 2019
Figure 64. China Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Gastric Antisecretory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Gastric Antisecretory Drug Sales Market Share by Countries in 2019
Figure 71. South America Gastric Antisecretory Drug Revenue Market Share by Countries in 2019
Figure 72. Brazil Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Gastric Antisecretory Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Gastric Antisecretory Drug Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Gastric Antisecretory Drug Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Gastric Antisecretory Drug Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Gastric Antisecretory Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Gastric Antisecretory Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Gastric Antisecretory Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Gastric Antisecretory Drug Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Gastric Antisecretory Drug Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Gastric Antisecretory Drug Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Gastric Antisecretory Drug Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Gastric Antisecretory Drug Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Bayer、Takeda、Jiangsu Aosaikang、Cadila Pharmaceuticals、Altana Pharma、AstraZeneca、Luoxin、Pfizer、Eisai、NCPC

★調査レポート[世界の胃抗分泌薬市場2020年:製造業者別、地域別、種類・用途別] (コード:GIR20SP11444)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の胃抗分泌薬市場2020年:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆